Clinical laboratories are an important part of the healthcare field. Most diagnostic tests, starting from the blood test to the genetic analysis, are conducted in these clinical laboratories to detect different diseases. Clinical laboratories offer data and resources that optimize the required distribution in the healthcare system, such as diagnostics and test results. This maintains and provides reliable and correct test results that enable doctors to make appropriate clinical and diagnostic decisions across various levels of health care services. This allows clinicians to adapt, begin, and stop treatment, which would be hindered in the absence of medical laboratory facilities.
Access Full Report at @ https://www.databridgemarketresearch.com/reports/europe-clinical-laboratory-services-market
Data Bridge Market Research analyzes that the Europe Clinical Laboratory Services Market is expected to reach USD 142,830.94 million by 2030, growing with a CAGR of 6.6% in the forecast period of 2023 to 2030. the enzyme-linked immunosorbent assay segment is projected to propel the market growth as it is a widely used and cost-effective method for detecting various diseases and infections.
Key Findings of the Study
Rise in the Cases of Infectious Diseases
In recent times, there has been an increasing incidence of infectious diseases, such as viral outbreaks and antibiotic-resistant pathogens that has raised the demand for diagnostic testing and clinical laboratory services. Infectious diseases affected by organisms such as viruses, parasites, fungi, and bacteria are directly or indirectly passed from one person to another. The clinical laboratories are investing substantially in advanced diagnostic technologies, including molecular diagnostics and serology testing, to effectively identify and manage these diseases. Increasing infectious diseases impact increasing the demand for clinical laboratories as laboratory diagnosis of infectious diseases of the patients.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD million
|
|
Segments Covered
|
Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs Of Abuse Testing, Anatomic Pathology Services, Cytology Testing, Genetic Testing, and Other Esoteric Testing), Technology (ChemiluminescenceImmunoassay, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Real-Time PCR, DNA Sequencing, Flow Cytometry, and Other Technologies), Provider (Independent & Reference Laboratories, Hospital-Based Laboratories, Clinical Based Laboratories, and Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services and Development Related Services, Bioanalytical & Lab Chemistry Services, Toxicology Testing Services, Cell & Gene Therapy Related Services, Preclinical & Clinical Trial Related Services, and Other Clinical Laboratory Services)
|
|
Countries Covered
|
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe
|
|
Market Players Covered
|
Abbott (U.S.), Sonic Healthcare Limited (Australia), SYNLAB International GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthineers AG (Germany), Mayo Foundation for Medical Education and Research (U.S.), Cerba HealthCare (France), amedes Medical Services GmbH (Germany), UNILABS (Switzerland), H.U. Group Holdings, Inc. (Japan), Eurofins Scientific (Germany), Charles River Laboratories (U.S.), Exact Sciences Corporation (U.S.), ACM Global Laboratories (U.S.), and Q2 Solutions (A subsidiary of IQVIA Inc) (U.S.) and among others
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and pestle analysis.
|
Segment Analysis
Europe clinical laboratory services market is segmented into four notable segments based on specialty, technology, provider and application.
- On the basis of specialty, the market is segmented into clinical chemistry testing, hematology testing, microbiology testing, immunology testing, drugs of abuse testing, cytology testing, Genetic Testing, anatomic pathology services and other esoteric testing.
In 2023, clinical chemistry testing segment is expected to dominate the Europe clinical laboratory services market
In 2023, the clinical chemistry testing segment is expected to dominate the market with a market share of 42.91%, due to the rise in cases of chronic diseases such as liver diseases, cardiovascular diseases and blood disorders which are increasing the demand to use clinical chemistry services.
- On the basis of technology, the market is segmented into enzyme-linked immunosorbent assay, real-time PCR, chemiluminescence immunoassay, Mass Spectrometry, Flow Cytometry, DNA sequencing, and other technologies.
In 2023, enzyme-linked immunosorbent assay segment is expected to dominate the Europe clinical laboratory services market
In 2023, the enzyme-linked immunosorbent assay segment is expected to dominate the market with a market share of 29.62%, as it is a widely used and cost-effective method for detecting various diseases and infections.
- On the basis of provider, the market is segmented into hospital-based laboratories, independent & reference laboratories, nursing and physician office-based laboratories and clinic-based laboratories. In 2023, the hospital-based laboratories segment is expected to dominate the market with a 49.49% market share.
- On the basis of application, the market is segmented into drug discovery and development related services, bioanalytical & lab chemistry services, toxicology testing services, cell & gene therapy related services, preclinical & clinical trial related services and other clinical laboratory services. In 2023, the bioanalytical & lab chemistry services segment is expected to dominate the market with a 45.99% market share.
Major Players
Abbott (U.S.), Sonic Healthcare Limited (Australia), SYNLAB International GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthineers AG (Germany) are the major market players in the Europe clinical laboratory services market.
Market Developments
- In August 2023, Abbott received FDA clearance for its Alinity h-series hematology system, expanding its diagnostic Service lineup for complete blood counts (CBC) testing. This system is crucial in routine checkups, aiding in the screening of various disorders such as infections, anemia, immune system diseases, and blood cancers. The Alinity h-series comprises Alinity hq, an automated hematology analyzer, and Alinity hs, an integrated slide maker and stainer. Notably, Alinity HQ employs MAPSSTM technology for advanced cell identification using light scattering.
- In November 2022, Microba Life Sciences announced a strategic partnership with Sonic Healthcare Limited, a global leader in medical diagnostics. Sonic is set to acquire a 19.99% stake in Microba, with an option for an additional 5% pending shareholder approval.
- In June 2023, SYNLAB had an investment worth Euro 8 million (USD 8.75 million) in a cutting-edge medical care center in Florence's Manifattura Tabacchi. Spanning 4000m2, the facility will accommodate up to 200,000 patients annually, offering an extensive array of diagnostic services, including routine and specialty testing, advanced imaging, and a unique women's health and prevention area.
- In January 2022, SYNLAB acquired Sistemas Genómicos, a prominent laboratory specializing in genetics and bioinformatics within the Ascires Group in Spain. This acquisition strengthens SYNLAB's position in the European genetics market by integrating Sistemas Genómicos' expertise in genetics, bioinformatics, sequencing, molecular biology, and molecular genetics.
- In November 2022, Siemens Healthineers AG introduced two groundbreaking MRI scanners, the 7 Tesla Magnetom Terra.X1, and the 3 Tesla Magnetom Cima.X2, designed for clinical and scientific applications.
Regional Analysis
Geographically, the countries covered in the Europe clinical laboratory services market report are Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland and Rest of Europe.
As per Data Bridge Market Research analysis:
Germany is expected to be the dominant and fastest-growing country in the Europe clinical laboratory services market during the forecast period 2023–2030
Germany is expected to be the dominant and fastest-growing country in the Europe clinical laboratory services market due to its advanced healthcare infrastructure and extensive network of high-quality clinical laboratories.
For more detailed information about the Europe clinical laboratory services market report, click here – https://www.databridgemarketresearch.com/reports/europe-clinical-laboratory-services-market
